Summary
In 1Q FY12/2026, the company posted revenue of JPY 5.1B (+20.9% YoY) and adjusted operating income of JPY 203M, sustaining a QoQ earnings growth trajectory and delivering a strong start against the full-year plan. During the briefing, management discussed new AI business initiatives not detailed in the earnings materials, including automated form generation through voice integration with BONX and AI agent applications. Management explicitly stated its intention to actively pursue diversified M&A going forward, in addition to the first-ever acquisition of installation company Laska, and emphasized the competitive advantage of onsite data infrastructure in the Physical AI era.
Key Points (Earnings Takeaways And Growth Actions)
- Corporate Strategy And Market Outlook
- Recognizes the onset of the Physical AI era against the backdrop of structurally worsening labor shortages; explicitly states that ownership of primary onsite data is a key source of competitive advantage
- Amid intensifying competition among AI vendors, positions its dual strengths as 370K real-time video data streams and an AI mass-production platform
- In the shift of AI applications from the web to physical spaces, cameras are positioned as indispensable—serving as "the eyes of AI and robots"
- Current Business Progress And Drivers
- Safie PRO direct-sales billable camera units grew +33.3% YoY, driving overall growth; Safie Trail Station enterprise adoption is accelerating
- Solution revenue reached JPY 222M, with diversification progressing through BONX integration and AI traffic survey projects
- Recurring gross margin of 62.3% dipped slightly on FX impact, but spot gross margin held at a strong 25.9%, bringing the overall gross margin to 52.3%
- Strategic Initiatives And Inflection Points
- Brought installation company Laska into the group to drive in-house installation and maintenance, building a nationwide deployment framework
- Established a structure leveraging Safie AI Studio as the foundation to enable low-cost AI model utilization, retraining, and new development
- Entered into a business alliance with Ailytics for full-scale deployment of unsafe behavior detection AI at construction sites
Outlook And Strategy
- No changes to full-year guidance. In 2Q, the company plans to increase advertising, personnel, and office-related expenses, and quarterly profits are expected to show some lumpiness
- Developing a construction site automated form generation solution through video × voice integration with BONX; also exploring enhanced information sharing leveraging AI agents
- In retail, promoting "whole-store Safie-fication" package deployments at Sugi Pharmacy and a major fashion accessories chain, with plans for rollout across several hundred stores
- Building an AI security service in partnership with Central Security Patrols (CSP), with a concept encompassing on-site dispatch and 110 emergency call response
- Management has explicitly committed to continued execution of diversified M&A, expressing strong interest in investments and acquisitions that advance onsite AX
- Expanding the addressable market by penetrating the ~9M installed on-premise camera base, with sights set on a domestic potential market of ~40M units
Positive Factors
- Commanding #1 position with 54.3% cloud recording service market share (2025); 370K onsite data infrastructure serves as a key differentiator for AI mass production
- ARR of JPY 14.996B (+21.5% YoY) and 370K billable camera units (+20.9% YoY)—focus KPIs sustaining 20%+ growth
- Safie PRO 12-month average churn rate remains low at 0.8% company-wide and 0.5% for direct sales, underpinning a stable recurring revenue base
- Rich pipeline of cross-industry new solutions leveraging generative AI, including snow accumulation monitoring, waste assessment, and automated form generation
- Emerging subsidies for camera deployment in the nursing care sector, expanding the addressable opportunity in new verticals such as fall detection AI
- Confirmed enterprise customer expansion cycle, exemplified by Sugi Pharmacy achieving ~8x camera deployment growth within two years of initial adoption
Concerns
- Advertising, personnel, and office-related expenses set to increase in 2Q for enterprise customer acquisition, potentially leading to a temporary dip in quarterly earnings
- FX-driven (yen depreciation) cloud cost increases are pressuring recurring gross margin (62.6% → 62.3%); prolonged yen weakness warrants attention regarding margin impact
- Gross profit per employee declined from JPY 20.5M to JPY 18.8M; progress on productivity improvements commensurate with headcount growth is a key monitoring point
- ARPC (average revenue per camera) edged down from JPY 41.0K to JPY 40.5K; the pace of ARPU uplift through AI solution attach remains a challenge
- M&A strategy is still in its initial execution phase; PMI track record and goodwill risk assessment are yet to be demonstrated
- Merchandise (inventory) increased +52.9% from JPY 874M to JPY 1,337M; appropriateness of inventory levels warrants attention
Performance Highlights
In 1Q FY12/2026, revenue was JPY 5,107M (+20.9% YoY), gross profit was JPY 2,669M (+28.4% YoY), and gross margin improved to 52.3%. Adjusted operating income surged to JPY 203M (vs. JPY 59M in the prior-year period, +244%), marking the fifth consecutive quarter of profitability. GAAP operating income also flipped to a JPY 105M profit (vs. a JPY 20M loss in the prior-year period), representing significant YoY improvement across the board.
Segment Performance
| Revenue Category | Revenue | YoY | Gross Profit | Gross Margin |
|---|---|---|---|---|
| Spot Revenue | JPY 1,407M | +19.3% | JPY 364M | 25.9% |
| Recurring Revenue | JPY 3,699M | +21.5% | JPY 2,304M | 62.3% |
| Total | JPY 5,107M | +20.9% | JPY 2,669M | 52.3% |
- ARR: JPY 14,996M (+21.5% YoY)
- Billable Camera Units: 370K (+20.9% YoY)
- ARPC: JPY 40.5K (vs. JPY 40.3K in the prior-year period)
- Solution Revenue: JPY 222M
- Safie PRO 12-Month Average Churn Rate (Company-Wide): 0.8%
- Gross Profit Per Employee: JPY 18.8M
- Headcount (April 2026): 616
- Adjusted Operating Income: JPY 203M (+JPY 64M QoQ)
Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.
- Use for Other Investment Products
Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.